Epstein-Barr virus as a marker of biological aggressiveness in breast cancer

por Mazouni, C, Fina, F, Romain, S, Ouafik, L, Bonnier, P, Brandone, J-M, Martin, P-M
Publicado 2011

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.

por Charpin, C., Garcia, S., Bouvier, C., Martini, F., Lavaut, M. N., Allasia, C., Bonnier, P., Andrac, L.
Publicado 1997

Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome

por Charpin, C, Giusiano, S, Charfi, S, Secq, V, Carpentier, S, Andrac, L, Lavaut, M-N, Allasia, C, Bonnier, P, Garcia, S
Publicado 2009

Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)

por Dales, J P, Garcia, S, Carpentier, S, Andrac, L, Ramuz, O, Lavaut, M N, Allasia, C, Bonnier, P, Taranger-Charpin, C
Publicado 2004

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

por Garcia, S, Dalès, J-P, Jacquemier, J, Charafe-Jauffret, E, Birnbaum, D, Andrac-Meyer, L, Lavaut, M-N, Allasia, C, Carpentier-Meunier, S, Bonnier, P, Charpin-Taranger, C
Publicado 2007

Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up

por Genet, D, Lejeune, C, Bonnier, P, Aubard, Y, Venat-Bouvet, L, Adjadj, D J, Martin, J, Labourey, J L, Benyoub, A, Clavère, P, Lebrun-Ly, V, Juin, P, Piana, L, Tubiana-Mathieu, N
Publicado 2007

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

por Fina, F, Romain, S, Ouafik, L'H, Palmari, J, Ayed, F Ben, Benharkat, S, Bonnier, P, Spyratos, F, Foekens, J A, Rose, C, Buisson, M, Gérard, H, Reymond, M O, Seigneurin, J M, Martin, P M
Publicado 2001